|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 202 of 212 found articles
| Title: |
154TiP AdvanTIG-204: Anti-TIGIT monoclonal antibody (mAb) ociperlimab (OCI) plus anti-PD-1 mAb tislelizumab (TIS) plus concurrent chemoradiotherapy (cCRT) in patients (pts) with untreated limited-stage small cell lung cancer (LS-SCLC) |
| Author: |
Lu, Y. Gong, Y. Kang, J-H. Whan Ree, J. Chen, X. Lin, X. Zhang, J. Borghaei, H. |
| Appeared in: |
Annals of oncology |
| Paging: | Volume 33 () nr. S2 pages S103 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
European Society for Medical Oncology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 202 of 212 found articles
| << previous | next >> |